In our analysis, although we sampled only a fraction of the tumor, the similar cell age estimated for MDM4+/EGFR+ and MDM4+/PDGFRA+ clones suggested that neither of these clones gained selective advantage during tumor growth. The gene discussed is EGFR; the disease is neoplasm.